Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:05 pm Sale | 2024-09-30 | 13G | Orchard Therapeutics plc ORTX | Blue Owl Capital Holdings LP | 0 0.000% | -15,596,600 (Position Closed) | Filing History |
| 2024-11-14 09:38 am Sale | 2024-09-30 | 13G | Orchard Therapeutics plc ORTX | Deep Track Capital, LP | 0 0.000% | -19,125,150 (Position Closed) | Filing History |
| 2024-02-14 9:05 pm Purchase | 2023-12-31 | 13G | Orchard Therapeutics plc ORTX | Blue Owl Capital Holdings LP | 15,596,600 6.850% | 15,596,600 (New Position) | Filing History |
| 2024-02-14 6:35 pm Unchanged | 2023-12-31 | 13G | Orchard Therapeutics plc ORTX | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-12 12:03 pm Sale | 2024-02-09 | 13G | Orchard Therapeutics plc ORTX | FMR LLC | 0 0.000% | -8,611,360 (Position Closed) | Filing |
| 2024-02-09 09:28 am Purchase | 2024-02-08 | 13G | Orchard Therapeutics plc ORTX | FMR LLC | 8,611,360 6.961% | 7,750,223 (+900.00%) | Filing |
| 2024-02-08 7:01 pm Purchase | 2023-12-31 | 13G | Orchard Therapeutics plc ORTX | Beryl Capital Management LLC | 15,614,990 6.900% | 2,114,990 (+15.67%) | Filing History |
| 2023-10-16 4:01 pm Purchase | 2023-10-05 | 13G | Orchard Therapeutics plc ORTX | Beryl Capital Management LLC | 13,500,000 5.900% | 13,500,000 (New Position) | Filing History |
| 2023-04-10 11:39 am Purchase | 2023-03-31 | 13G | Orchard Therapeutics plc ORTX | FEDERATED HERMES INC. FHI | 840,169 4.570% | 0 (+0.00%) | Filing History |
| 2023-03-20 4:43 pm Purchase | 2023-03-10 | 13G | Orchard Therapeutics plc ORTX | Deep Track Capital, LP | 19,125,150 9.990% | 19,125,150 (New Position) | Filing History |
| 2023-03-20 4:30 pm Purchase | 2023-03-10 | 13G | Orchard Therapeutics plc ORTX | RA CAPITAL MANAGEMENT L.P. | 18,564,300 9.990% | 18,564,300 (New Position) | Filing History |
| 2023-02-13 12:06 pm Purchase | 2022-12-31 | 13G | Orchard Therapeutics plc ORTX | CHI Advisors LLC | 798,740 6.300% | 153,754 (+23.84%) | Filing History |
| 2023-02-10 10:07 am Sale | 2022-12-31 | 13G | Orchard Therapeutics plc ORTX | James E. Flynn | 316,171 2.500% | -378,771 (-54.50%) | Filing History |
| 2023-02-09 09:19 am Purchase | 2022-12-31 | 13G | Orchard Therapeutics plc ORTX | Zentree Investments Ltd | 1,596,056 12.598% | 304,244 (+23.55%) | Filing History |
| 2023-02-01 11:25 am Purchase | 2022-12-31 | 13G | Orchard Therapeutics plc ORTX | FEDERATED HERMES INC. FHI | 840,169 6.630% | 9,183 (+1.11%) | Filing History |
| 2022-12-20 06:01 am Purchase | 2022-12-15 | 13G | Orchard Therapeutics plc ORTX | Zentree Investments Ltd | 1,291,812 10.197% | 644,065 (+99.43%) | Filing History |
| 2022-11-14 4:43 pm Sale | 2022-11-14 | 13G | Orchard Therapeutics plc ORTX | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -969,479 (Position Closed) | Filing History |
| 2022-09-09 10:11 am Purchase | 2022-09-01 | 13G | Orchard Therapeutics plc ORTX | Zentree Investments Ltd | 647,747 5.122% | 647,747 (New Position) | Filing History |
| 2022-05-09 12:55 pm Sale | 2022-04-30 | 13G | Orchard Therapeutics plc ORTX | Artisan Partners Limited Partnership | 332,274 2.600% | -649,337 (-66.15%) | Filing History |
| 2022-02-14 4:11 pm Sale | 2021-12-31 | 13G | Orchard Therapeutics plc ORTX | RA CAPITAL MANAGEMENT L.P. | 969,479 7.700% | -262,042 (-21.28%) | Filing History |